MedPath

Medication Adherence Enhancement in Heart Transplant Recipients

Not Applicable
Conditions
Medication Adherence
Self Management
Rejection
Registration Number
NCT00843960
Lead Sponsor
Hannover Medical School
Brief Summary

Medication-related non-adherence increases the risk of rejections and associated graft loss after solid organ transplantation. A randomized controlled intervention will use adherence enhancing strategies out of a larger sample of 300 heart transplant recipients. Non-Adherence will be assessed by patients' self-report and based on immunosuppression level. All non-adherent patients will be randomly designed to either intervention or control group. Multi-module interventions include patient education, electronic medication event monitoring, and a combined behavior and symptom management. Longitudinal follow-up is envisioned after initial intervention.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
150
Inclusion Criteria
  • all eligible patients with follow-up at our outpatient clinic
  • written informed consent
  • sufficient German language skills to read and answer a battery of questionnaires
  • > 18 years
  • minimum 6 mts post HTX
Exclusion Criteria
  • illiteracy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Occurrence of adverse events (composite endpoint)at month 60
Secondary Outcome Measures
NameTimeMethod
Adherence behavior measurement variables from MEMS systemfirst 3 month
Immunosuppression levelat month 60
All individual components of the composite endpoint occurence of adverse eventsat month 60

Trial Locations

Locations (1)

Clinic for Cardiac, Thoracic, Transplantation and Vascular Surgery

🇩🇪

Hannover, Germany

Clinic for Cardiac, Thoracic, Transplantation and Vascular Surgery
🇩🇪Hannover, Germany
Christiane Kugler, PhD
Contact
++49.511.532.
kugler.christiane@mh-hannover.de
Christoph Bara, MD
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.